Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JTS2400067	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Disposable Import Drug Application	2024-08-08					view
JYSZ2400007	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
JYSZ2400008	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
JYSZ2400009	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
CXSS2300097	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products(3.4)	New Drug Application	2023-12-14		Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group			view
JYSB2300059	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB2300061	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB2300060	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB2101208	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSB2101206	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSB2101207	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
CXSL2000306	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products(2.4)	New Drug Application	2020-10-28	成都蓉生药业有限责任公司	Chengdu Rongsheng Pharmaceuticals Co Ltd	In Review	2020-10-27	view
JYSB2000199	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-05-20	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-05-29	view
JYSB2000201	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-05-20	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-05-29	view
JYSB2000200	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-05-20	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-05-29	view
JYSB2000125	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-04-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-11-24	view
JYSB2000124	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-04-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-11-24	view
CXSL2000034	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products(10)	New Drug Application	2020-02-27	正大天晴药业集团股份有限公司	Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd	In Review	2020-02-26	view
JYSZ1900037	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2019-07-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-02	view
JYSZ1900036	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2019-07-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-02	view